https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53913 Wed 28 Feb 2024 15:58:52 AEDT ]]> The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51182 Tue 03 Oct 2023 19:34:38 AEDT ]]> Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50946 Mon 14 Aug 2023 14:01:12 AEST ]]> A road map for the treatment of pediatric diffuse midline glioma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53880 Fri 19 Jan 2024 12:44:57 AEDT ]]>